OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 02, 2011
The European Commission and Medicines Agency seem to be moving in advance of their ICH partners to update standards.
Expert and implementation working groups harmonize more guidelines and move Q11 forward.
Industry executives share insight into the future direction of drug manufacturing and the supply chain. This article contains online bonus material.
Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.
Capable of great works, pharma as a whole still yields to the lesser angels of its nature.
A Q&A with Spectrum Laboratories President Tony MacDonald.
Holding product and supply-chain security to the highest standards is crucial for the future.
Industry experts offer their best practices for dealing with deviations. This article contains online bonus material.
CDMOs and CMOs face weak economic recovery, consolidation, and globalization.
December 30, 2010
AstraZeneca and Abbott End Program; PhRMA Elects New Members; and More.